!!Projects per year
指紋
查看啟用 Alexander Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
專案
- 23 已完成
-
探討魚針草酸透過調控癌幹細胞外泌體達到重朔免疫微環境及克服免疫療法抗性頭頸癌之轉譯研究(1/3)
Wu, A. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
開發心肌梗塞後綜合治療診斷系統應用於特定階段的心血管修復和再生－運用心臟保護胜肽（CPPs）提升間質幹細胞外泌體（sEVs）功能性達到更精準的心肌梗塞治療與預防(1/3)
Wu, A. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
A Translational Investigation of Generating Enhanced Mscs and Secretome Using Mfp-Based Proprietary Culture Methods for Dcli Treatment(3/3)
Wu, A. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
A Translational Investigation of Generating Enhanced Mscs and Secretome Using Mfp-Based Proprietary Culture Methods for Dcli Treatment(2/3)
Wu, A. (PI)
8/1/23 → 7/31/24
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
Corrigendum “Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of it major phytoconstituents”(Biomedicine & Pharmacotherapy, (2022), 152, C, (113196), (S0753332222005856), 10.1016/j.biopha.2022.113196)
Lawal, B., Sani, S., Onikanni, A. S., Ibrahim, Y. O., Agboola, A. R., Lukman, H. Y., Olawale, F., Jigam, A. A., Batiha, G. E. S., Babalola, S. B., Gomaa, M. H., Lima, C. M. G., Wu, A. T. H., Huang, H. S. & Conte-Junior, C. A., 2026, (接受/付印) 於: Biomedicine and Pharmacotherapy. 199, 119308.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation
Yang, C. H., Renantha, R. R., Hsu, P. C., Wu, A. T., Wu, S. Y., Azizah, N., Ritmaleni, R., Chen, J. H., Lee, J. C., Fang, C. Y. & Lin, K. C., 1月 2026, 於: Journal of Dental Sciences. 21, 1, p. 282-293 12 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection
Lin, C., Tsai, M. L., Chao, H. Y., Cheng, T. M., Shih, C. M., Wu, A. T. H., Cheng, C. H., Hsiao, C. Y., Lu, H. Y., Shih, C. C. & Mi, F. L., 12月 2026, 於: Journal of Nanobiotechnology. 24, 1, 41.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取4 連結會在新分頁中打開 引文 斯高帕斯（Scopus） -
Bioprospection of Hura crepitans metabolites against oxidative stress and inflammation: An in vitro and in silico exploration
Kuo, Y. C., Lawal, B., Lukman, H. Y., Chen, L. C., Huang, S. L., Chen, Y. F., Fadaka, A. O., Olawale, F., Olasupo, A., Ajenifujah, O. T., Fouad, D., Papadakis, M., Batiha, G. E. S., Sabiu, S., Wu, A. T. H. & Huang, H. S., 2025, 於: International Journal of Medical Sciences. 22, 8, p. 1837-1851 15 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60
Tang, S. L., Sumitra, M. R., Kuo, Y. C., Hsu, H. L., Ansar, M., Huang, S. L., Lee, S. Y., Wang, H. J., Lawal, B., Wu, A. T. H., Chen, L. C. & Huang, H. S., 7月 2025, 於: Computers in Biology and Medicine. 193, 110445.研究成果: 雜誌貢獻 › 文章 › 同行評審
2 連結會在新分頁中打開 引文 斯高帕斯（Scopus）
資料集
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
資料集: Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
資料集: Dataset
-
Additional file 1: Table S1. of Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
Bamodu, O. A. (Contributor), Lee, W.-H. (Contributor), Chao, T.-Y. (Contributor), Huang, W.-C. (Contributor), Yeh, C.-T. (Contributor), Wu, A. (Creator), Hsiao, M. (Creator) & Wang, L. S. (Creator), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3621719_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3621719_d1.v1
資料集: Dataset
-
Additional file 2: Figure S1. of Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
Yeh, C.-T. (Contributor), Huang, W.-C. (Contributor), Wu, A. (Creator), Bamodu, O. A. (Contributor), Lee, W.-H. (Contributor), Wang, L. S. (Creator), Chao, T.-Y. (Contributor) & Hsiao, M. (Creator), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3621719_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3621719_d3.v1
資料集: Dataset
-
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huynh, T.-T. (Contributor), Tzeng, Y.-M. (Contributor), Yen, Y. (Creator), Yang, C.-K. (Contributor), Wu, A. T. (Creator), Meng, T.-C. (Contributor), Whang-Peng, J. (Creator), Wei, P.-L. (Contributor), Hsiao, M. (Creator) & Huang, Y.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533_d1.v1
資料集: Dataset